Literature DB >> 6979882

Digital subtraction pulmonary angiography.

P C Goodman, M Brant-Zawadzki.   

Abstract

Digital subtraction pulmonary angiography was performed in 14 patients suspected of having pulmonary embolism. In 13 of 14, useful clinical information was obtained. Four patients were found to have pulmonary emboli. In nine patients, digital subtraction angiography was performed through pulmonary artery catheters already in place for monitoring critically ill patients. Conventional angiography in nine patients confirmed the findings by digital angiography. This initial experience suggests that digital subtraction pulmonary angiography provides adequate image quality in certain circumstances with several advantages over conventional angiography.

Entities:  

Mesh:

Year:  1982        PMID: 6979882     DOI: 10.2214/ajr.139.2.305

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Diagnostic approach to pulmonary embolism: our strategy.

Authors:  A Vincent; S Poli; C Perret
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

2.  Current experience with digital subtraction angiography in the community medical center.

Authors:  S J Hessel; J M Levy; J K Crowe; P W Nykamp; R M Spiegel; C J Stegman; W W Horsley
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

3.  Digital subtraction pulmonary angiography--an internist's and radiologist's view.

Authors:  S Z Goldhaber; J Markisz
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

4.  The use of digital subtraction angiography in evaluating pulmonary abnormalities in children.

Authors:  M L Wagner; E B Singleton; M E Egan
Journal:  Tex Heart Inst J       Date:  1985-03

5.  Automated analysis method to assess pulmonary blood flow distribution using conventional X-ray angiography.

Authors:  Takuya Sakaguchi; Yuichiro Watanabe; Masashi Hirose; Kohta Takei; Satoshi Yasukochi
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.